B+
Bull case
25%
Probability
Target price
$36.00
Analysis reference price unavailable
Analysis 2026-10-18 · RankAlpha Sentiment Codex
HROW
HarrowCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
VEVYE coverage, IHEEZO pricing and unit demand, and the newly acquired TYRVAYA portfolio could support the substantial second-half acceleration needed to meet reiterated guidance [#SEC-8K-2026-08-10] [#8-K-2026-10-05].
Posture
Mixed
Lead driver
Value
What changed
3 setup hits (3d) with net bullish as of 2026-10-24.
What can break
IHEEZO lost pass-through reimbursement; better unit demand must translate into durable net pricing and margins [#SEC-8K-2026-08-10].
Momentum
12
Value
55
Sentiment
57
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $30.00 · Bull $36.00 · Bear $20.00Analysis 2026-10-18; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-18 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $65.00
Why
Momentum12 · Δ7d +2.3
Value55 · Δ7d -0.2
Sentiment57 · Δ7d -24.2
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 3 setup hits (3d) with net bullish as of 2026-10-24.
- • Value remains the lead driver in the composite, 7D delta -0.2.
Contradictions & invalidation
- • IHEEZO lost pass-through reimbursement; better unit demand must translate into durable net pricing and margins [#SEC-8K-2026-08-10].
- • Independent analyst revisions, current cash and leverage following the acquisition, and direct small-cap ophthalmic valuation peers are not established by the packet.
- • Management said first-half revenue was lighter than expected.
Catalyst clock
2026-12-31
VEVYE access and IHEEZO economics
Lead driver: Value · See fundamentals
Momentum
12
8% active weight
Current posture
7d trendFlat
Δ7d
+2.3
Δ21d
+2.0
Value
55
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.8
Sentiment
57
45% active weight
Current posture
7d trendSoftening
Δ7d
-24.2
Δ21d
-22.2
Why this grade
Composite grade C. Momentum 11.6 / Value 55.4 / Sentiment 57.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-18. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$30.00
Analysis reference price unavailable
Analysis 2026-10-18 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$20.00
Analysis reference price unavailable
Analysis 2026-10-18 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$1.07B
Beta
0.07
Shares Out
37.49M
P/E (TTM) · Derived
-203.4
P/S (TTM)
8.12
P/FCF (TTM) · Derived
243.08
Rev YoY
+10.9%
EPS YoY
-459.6%
Gross Margin
+73.3%
Op Margin
+2.1%
Net Debt
$179.05M
Current Ratio
2.24
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data